Background In 2012, a European initiative called S ingle H ub and A ccess point for pediatric
R heumatology in E urope (SHARE) was launched to optimise and disseminate diagnostic …

The idiopathic inflammatory myopathies, including adult and juvenile dermatomyositis (DM),
polymyositis (PM), and inclusion body myositis (IBM), are rare systemic autoimmune …

Dermatomyositis (DM) is an idiopathic inflammatory myopathy that commonly manifests with
proximal muscle weakness and is associated with extramuscular pathology including …

BACKGROUND: The COVID pandemic has impacted almost every aspect of human
interaction, causing global changes in financial, health care, and social environments for the …

Objectives Juvenile myositis is a rare and heterogeneous disease. Diagnosis is often difficult
but early treatment is important in reducing the risk of associated morbidity and poor …

Objective To investigate the long‐term outcome and prognostic factors of juvenile
dermatomyositis (DM) through a multinational, multicenter study. Methods Patients consisted …

Recently, there have been important advances in the understanding of the pathophysiologic
features, assessment, and management of patients with a newly diagnosed idiopathic …

Recent studies have shown increased expression of interferon (IFN)-regulated genes in the
peripheral blood cells of patients with systemic lupus erythematosus. A similar interferon …

Introduction The aim of this study was to define the frequency and associated clinical
phenotype of anti-MDA5 autoantibodies in a large UK based, predominantly Caucasian …

Objective. Calcinosis is a major cause of morbidity in JDM and has previously been linked to
anti-NXP2 autoantibodies, younger age at disease onset and more persistent disease …